WORK Medical Technology Group LTD income statement WOK

Annual Quarterly

In fiscal 2025, which ended Sep 30, 2025, WORK Medical Technology Group LTD reported revenue of $9.8 million, down 14.4% from the year before. It recorded a net loss of $1.1 million. Diluted earnings per share were -$0.04.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
Revenue
10
-14.4%
12
Gross profit
2
-18.3%
3
Research and development
0
+43.9%
0
Selling, general and administrative
4
-33.4%
7
Pretax income
-1
+70.5%
-4
Income tax
0
+195.0%
-0
Net income
-1
+69.3%
-3
Basic EPS
-0.04
+85.2%
-0.27
Diluted EPS
-0.04
+85.2%
-0.27
Weighted average shares, basic
29
+128.1%
13
Weighted average shares, diluted
29
+128.1%
13
Other measures
Depreciation and amortization
1
-34.6%
1
Margins
Gross margin
23.81%
24.93%
Pretax margin
-10.99%
-31.86%
Profit margin
-10.89%
-30.35%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
WOK (Nasdaq)
Fiscal year ends
September 30
Incorporated in
China
Headquarters
Auckland City
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1929783
Former names
WORK Medical Technology Group LTD (until Nov 4, 2026); WORK Medical Technology LTD (until Jun 23, 2022)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.